This is a recorded session from the SGIM 2025 Annual Meeting in Florida.
Cardiovascular (CV) disease remains the leading cause of death in the United States. Three of the biggest contributors to CV disease are chronic conditions managed by general internists: diabetes, hypertension, and hyperlipidemia. Presenters review literature from the past two years to identify practice-changing studies on these three CV risk factors. They will summarize study design, key findings, and strengths and limitations, as well as discuss the study’s impact on clinical care.
- Identify diabetes, hypertension, and hyperlipidemia as major preventable causes of CV morbidity and mortality in the United States
- Outline new approaches to behavior, nutrition, and lifestyle medicine for CV risk reduction
- Apply updates in pharmacotherapy and interventional therapies in the realm of CV risk reduction to the clinical practice of general internal medicine
Expiration: June 1, 2027
To receive CME credit only, you must (1) watch the entire presentation, then (2) click the Certificate item to claim your certificate (print/save for your records).
To receive CME and MOC credit, you must (1) watch the entire presentation, (2) complete the brief MOC Assessment survey, and then (3) click the Certificate item to claim your certificate (print/save for your records).
- Benjamin Gallagher, MD
Yale School of Medicine - Kelsey Bryant, MD MPH MS
Icahn School of Medicine at Mount Sinai - Eva Tseng, MD MPH
Johns Hopkins University School of Medicine - Jennifer Cluett, MD
Beth Israel Deaconess Medical Center - Allison Crawford, MD
University of California, San Francisco School of Medicine
